Myozyme and fatigue 
Myozyme and fatigue Patient Reports February 12, 2012
Myozyme Side Effects Report #6112212-X
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 25, 2009. Male patient, child 9 years of age, weighting 72.53 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: disease progression, dysstasia, fatigue, movement disorder
, muscular weakness, peroneal nerve palsy, restrictive pulmonary disease. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS; 5 MG/KG, 2X/W, INTRAVENOUS; 10 MG/KG, QW. Patient recovered.Myozyme Side Effects Report #5847413-9
Myozyme side effect was reported by a Physician from GERMANY on Aug 04, 2008. Male patient, 60 years of age, weighting 262.4 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: fatigue, feeling hot, myalgia, nausea
. Myozyme dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, RAMIPRIL, LEVOTHYROXINE. Patient recovered.Myozyme Side Effects Report #5850897-3
Myozyme side effect was reported by a Physician from GERMANY on Aug 12, 2008. Male patient, 60 years of age, weighting 262.4 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: fatigue, feeling hot, myalgia, nausea
. Myozyme dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, RAMIPRIL, LEVOTHYROXINE. Patient recovered.Myozyme Side Effects Report #5887099-0
Myozyme side effect was reported by a Health Professional from GERMANY on Aug 12, 2008. Male patient, 60 years of age, weighting 262.4 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: fatigue, feeling hot, infusion related reaction, myalgia, nausea
. Myozyme dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, BISOPRLOL, RAMIPRIL. Patient recovered.Myozyme Side Effects Report #5853417-2
Myozyme side effect was reported by a Physician from ISRAEL on Aug 06, 2008. Female patient, child 6 years of age, weighting 44.09 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: activities of daily living impaired, chills, face oedema, fatigue, flushing, heart rate increased, hypersensitivity, infusion related reaction, nonspecific reaction. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #5942624-6
Myozyme side effect was reported by a Physician from ISRAEL on Oct 22, 2008. Female patient, child 6 years of age, weighting 39.68 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal pain
, asthenia, chills, developmental delay, diarrhoea, face oedema, fatigue, flushing, immunology test abnormal. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.Myozyme Side Effects Report #5950872-4
Myozyme side effect was reported by a Physician from ISRAEL on Oct 29, 2008. Female patient, child 6 years of age, weighting 44.09 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, blood pressure systolic increased, chills, dizziness
, exposure to communicable disease, face oedema, fatigue, flushing, heart rate increased. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.Myozyme Side Effects Report #5353601-0
Myozyme side effect was reported by a Physician from FRANCE on May 25, 2007. Male patient, 57 years of age, weighting 216.1 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cough, dyspnoea, fatigue, lung infection, pulmonary congestion. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with MUCOMYST. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5369681-2
Myozyme side effect was reported by a Physician from FRANCE on June 07, 2007. Male patient, 57 years of age, weighting 216.1 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: condition aggravated, fatigue, lung infection, pulmonary congestion, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with MUCOMYST. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5205594-4
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on July 25, 2006. Female patient, 52 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: fatigue. Myozyme dosage: 20 MG/KG, Q2WKS; IV. Patient recovered.
Myozyme Side Effects Report #5201827-9
Myozyme side effect was reported by a Physician from HUNGARY on Dec 21, 2006. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal distension, dizziness
, dyspnoea, fall , fatigue, hyperhidrosis, hypertension, muscular weakness, pallor. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with SUPRASTIN. Patient recovered.Myozyme Side Effects Report #5233627-8
Myozyme side effect was reported by a Physician from HUNGARY on Jan 24, 2007. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal distension, anaphylactic reaction, fall
, fatigue, muscular weakness, poor peripheral circulation. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with SUPRASTIN, TELFAST, CALCIUM GLUCONATE. Patient recovered.Myozyme Side Effects Report #5248066-3
Myozyme side effect was reported by a Physician from HUNGARY on Feb 07, 2007. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: abdominal distension, anaphylactic reaction, blood immunoglobulin e increased, chest pain
, conjunctivitis, fall , fatigue, fear, hypertension. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with SUPRASTIN, CALCIUM GLUCONATE, TELFAST, CALCIUM GLUCONATE. Patient recovered.Myozyme Side Effects Report #5454997-1
Myozyme side effect was reported by a Physician from AUSTRALIA on Aug 30, 2007. Female patient, child 3 years of age, weighting 33.73 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, diarrhoea, dysphagia, fall
, fatigue, muscular weakness. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient recovered.Myozyme Side Effects Report #5807094-7
Myozyme side effect was reported by a Physician from UNITED KINGDOM on June 24, 2008. Male patient, child 3 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, fatigue, pyrexia. Myozyme dosage: 20 MG, Q2W, INTRAVENOUS. Patient recovered.
Myozyme Side Effects Report #6081258-2
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 02, 2009. Male patient, child 3 years of age, weighting 37.48 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, anxiety
, blood pressure decreased, bronchospasm, cyanosis, fatigue, feeding tube complication, flushing, heart rate increased. Myozyme dosage: 350 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, DECADRON. Patient recovered.Myozyme Side Effects Report #6101010-9
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 17, 2009. Male patient, child 3 years of age, weighting 37.48 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, anxiety
, blood pressure decreased, bronchospasm, cyanosis, fatigue, flushing, heart rate increased, hypoxia. Myozyme dosage: 350 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, DECADRON. Patient recovered.Myozyme Side Effects Report #6125057-1
Myozyme side effect was reported by a Physician from UNITED STATES on Mar 05, 2009. Male patient, child 3 years of age, weighting 37.48 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, antibody test positive, anxiety
, blood pressure decreased, bronchospasm, cyanosis, fatigue, flushing, hypoxia. Myozyme dosage: 350 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, DECADRON. Patient recovered.Myozyme Side Effects Report #6137899-7
Myozyme side effect was reported by a Physician from UNITED STATES on Mar 17, 2009. Male patient, child 3 years of age, weighting 37.48 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: agitation, anxiety
, blood pressure decreased, bronchospasm, cyanosis, fatigue, flushing, heart rate increased, hypoxia. Myozyme dosage: 350 MG, Q2W, INTRAVENOUS. During the same period patient was treated with BENADRYL, ACETAMINOPHEN, DECADRON. Patient recovered.Myozyme Side Effects Report #5467536-6
Myozyme side effect was reported by a Physician from UNITED STATES on Sept 10, 2007. Female patient, 14 years of age, weighting 116.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: fatigue, muscular weakness. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient recovered.
Myozyme Side Effects Report #5226048-5
Myozyme side effect was reported by a Physician from BRAZIL on Jan 15, 2007. Female patient, weighting 14.00 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, bradycardia, choking
, cough, dysphagia, fatigue, haematocrit decreased, heart rate decreased, hypotension. Myozyme dosage: 20 MG/KG IV. During the same period patient was treated with PROPRANOLOL, FERROUS SULPHATE, HYDROCORTISONE, HYDROXYZINE. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5796377-5
Myozyme side effect was reported by a Physician from UNITED STATES on June 18, 2008. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac murmur, congestive cardiomyopathy, conjunctivitis, erythema, fatigue, heart rate increased, hypercapnia, hypotonia. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with LASIX, OXYGEN, ACETAMINOPHEN, MOTRIN. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5811792-9
Myozyme side effect was reported by a Physician from NETHERLANDS on July 03, 2008. Male patient, weighting 198.4 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: disease progression, fall
, fatigue, hypercapnia, muscular weakness. Myozyme dosage: 20 MG/KG, Q2W. During the same period patient was treated with CLEMANIL, HYDROCORTISONE. Patient recovered.Myozyme Side Effects Report #6137501-4
Myozyme side effect was reported by a Physician from ITALY on Mar 19, 2009. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: disease progression, fatigue, refusal of treatment by patient, respiratory disorder. Myozyme dosage: unknown. Patient was hospitalized. Patient recovered.